Keywords: Boehringer Ingeheim, USA, Justice Department, False claims allegations, Settlement

Boehringer Ingelheim to pay $95 million to resolve False Claims Act allegations in USA

Article | 29 October 2012

Print This

The US subsidiary of independent German drug major Boehringer Ingelheim has agreed to pay $95 million to resolve allegations under the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in